
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised an extension to the indication for Lynkuet (elinzanetant), allowing its …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University

